Healthcare entity
U.S. Congress is most often covered alongside Chuck Schumer, which appears in 1 of these 2 stories. Across a 111-day span, the pace is roughly 0.1 stories per week. Each story carries 9 original sources on average, compared with 3.6 for the broader beat in this window.
Last mentioned: Jun 28, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
U.S. Congress is most often covered alongside Chuck Schumer, which appears in 1 of these 2 stories. Across a 111-day span, the pace is roughly 0.1 stories per week. Each story carries 9 original sources on average, compared with 3.6 for the broader beat in this window. Coverage clusters in funding, which accounts for 1 of those 2, with the remainder spread across 1 other category. Their average consequence score of 7 runs above the beat's 6.1 for that window. U.S. Congress appears in 2 tracked Healthcare stories published from March 10, 2026 through June 28, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 453 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering U.S. Congress. Shared-story counts are live from our verified record — not editorial picks.
Buried within a predominantly military funding bill, $1.4 billion is earmarked for the Central African Ebola outbreak, highlighting the Obama administration’s continued commitment to global health even as geopolitical crises dominate fiscal priorities.
A new analysis reveals a 35% decline in antimicrobial R&D among the world's largest pharmaceutical companies over the last five years. This retreat highlights a deepening crisis in the antibiotic market, where low returns on investment are driving major players toward more lucrative therapeutic areas.
U.S. Congress is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
